SEEL Quote, Trading Chart, Seelos Therapeutics Inc.

$ Last:

2.60% Change Percent:

$0.79 Open:

$0.79 Previous Close:

$0.8382 High:

$0.78 Low:

966,621 Volume:

02/12/2020 04:39:52 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2020-02-12	0.79	0.79	0.8382	0.78	966,621
2020-02-11	0.764	0.77	0.82	0.762	3,685,500
2020-02-10	0.91	0.8545	0.91	0.83	757,511
2020-02-07	0.97	0.89	0.99	0.85	1,801,882
2020-02-06	0.9498	0.90	0.95	0.88	656,875
2020-02-05	0.9401	0.9666	1.04	0.9308	610,833
2020-02-04	1.00	0.9515	1.00	0.92	442,055
2020-02-03	1.04	0.98	1.0599	0.96	548,794
2020-01-31	1.09	1.04	1.10	1.01	323,374
2020-01-30	1.11	1.07	1.14	1.02	467,522
2020-01-29	1.22	1.16	1.22	1.12	270,962
2020-01-28	1.22	1.1901	1.2375	1.11	405,862
2020-01-27	1.20	1.13	1.2299	1.06	468,809
2020-01-24	1.22	1.22	1.30	1.22	338,872
2020-01-23	1.32	1.24	1.33	1.20	665,555
2020-01-22	1.40	1.345	1.44	1.34	647,881
2020-01-21	1.52	1.51	1.57	1.46	447,963
2020-01-20	1.46	1.52	1.53	1.44	677,638
2020-01-17	1.46	1.52	1.53	1.44	673,266
2020-01-16	1.43	1.44	1.48	1.42	175,445

Stock Information

Seelos Therapeutics Inc. Company Name:

SEEL Stock Symbol:

NYSE Market:

Seelos Therapeutics Inc. Website:

SEEL Quote, Trading Chart, Seelos Therapeutics Inc.

Get SEEL Alerts

News, Short Squeeze, Breakout and More Instantly...

SEEL - Help May be On the Way for Patients with Parkinson's Disease

Psychedelics could be a game-changer for millions dealing with depression, anxiety, addiction issues, PTSD, and even issues such as Parkinson’s disease. All of which is driving significant attention to companies like PharmaTher Holdings Ltd. (CSE: PHRM)(OTCQB: PHRRF), Mind Medi...
SEEL - Seelos Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic Lateral Sclerosis (ALS)

Seelos Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic Lateral Sclerosis (ALS) PR Newswire NEW YORK , April 20, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmac...
SEEL - Seelos Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference

Seelos Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference PR Newswire NEW YORK , April 19, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the developm...